Miracor buys 80% interest in Ultra Open MRI
MRI imaging service provider Miracor Diagnostics has completed its acquisition of 80% of Ultra Open MRI Holding, a multisite MRI business with offices in Tampa, St. Petersburg, and Palm Harbor, FL. Miracor, formerly Medical Device Technologies
MRI imaging service provider Miracor Diagnostics has completed its acquisition of 80% of Ultra Open MRI Holding, a multisite MRI business with offices in Tampa, St. Petersburg, and Palm Harbor, FL. Miracor, formerly Medical Device Technologies (SCAN 10/27/99), entered the imaging business in 1998 through the acquisition of MRI service sites in Ohio and Florida and added another site in Illinois last year. The companys stock is traded over the counter under the symbol MRDG.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
